GlassScriptPhysician profile
Kayota Tolbert
NPI 1215483441
$1,253.50
in general payments reported to CMS, 2019-2025
19 companies · $160 in 2025
The $160 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $222 · 2022: $326 · 2023: $445 · 2024: $101 · 2025: $160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $706.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $706.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $274.09 | 2022-2025 | |
| Abbvie INC. | $245.35 | 2021-2023 | |
| Abbott Laboratories | $119.69 | 2022-2024 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $106.44 | 2021-2025 | Arexvy, Bexsero, Shingrix |
| Novo Nordisk INC | $81.46 | 2021-2023 | Wegovy |
| Insulet Corporation | $66.52 | 2023-2024 | Omnipod |
| Amgen INC. | $57.56 | 2021-2022 | |
| Vertos Medical, INC. | $47.08 | 2021 | |
| Medtronic, INC. | $38.87 | 2022-2023 | Intellis Adaptivestim |
| Astellas Pharma US INC | $38.43 | 2024-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $34.05 | 2024-2025 | |
| Boston Scientific Corporation | $23.15 | 2025 | General - Pain Management |
| Pfizer INC. | $21.30 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.12 | 2022 | |
| Ucb, INC. | $18.95 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $17.28 | 2022 | |
| Lilly USA, LLC | $16.57 | 2021 | |
| Arbor Pharmaceuticals, INC. | $13.93 | 2021 | |
| Merck Sharp & Dohme LLC | $11.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kayota Tolbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.